Article Information
History
- April 15, 2020.
Article Versions
- Version 1 (March 26, 2020 - 10:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hongyan Zhang1,*,
- Linwei Wang1,*,
- Yuanyuan Chen1,*,
- Xiaokun Shen2,*,
- Qun Wang3,
- Youqin Yan4,
- Yi Yu5,
- Qiuji Wu1,
- Yahua Zhong1,#,†,
- Melvin L.K. Chua7,#,† and
- Conghua Xie1,#,†
- 1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Wuhan, China
- 2Convalife (Shanghai) Co., Ltd., Shanghai, China
- 3Department of Oncology, the Fifth Hospital of Wuhan, Wuhan, China
- 4Department of Infection, the Seventh Hospital of Wuhan, Wuhan, China
- 5Department of Oncology, Han Kou Hospital of Wuhan, Wuhan, China
- 6Divisions of Radiation Oncology and Medical Sciences, National Cancer Center Singapore, Singapore
- 7Oncology Academic Programme, Duke-NUS Medical School, Singapore
- ↵†Corresponding Authors:
Prof. Conghua Xie, Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan, Hubei Province, 430071, China, Tel: 86-027-67812607, E-mail: chxie_65{at}whu.edu.cn. Dr Melvin L.K. Chua, Division of Radiation Oncology, National Cancer Center Singapore, 11 Hospital Dr, Singapore 169610. Tel: 65-64368000, E-mail: melvin.chua.l.k{at}singhealth.com.sg. Prof. Yahua Zhong, Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan, Hubei Province, 430071, China, Tel: 86-027-67813154, E-mail: doctorzyh73{at}163.com
Posted April 15, 2020.
A Multicenter Study of Coronavirus Disease 2019 Outcomes of Cancer Patients in Wuhan, China
